ProShare Advisors’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

ProShare Advisors’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-9,034	Closed	-$231K	–	1816
2018 Q2	$231K	Buy	+9,034	New	+$211K	﹤0.01%	1531
2016 Q3	–	Sell	-6,404	Closed	-$224K	–	1543
2016 Q2	$224K	Buy	+6,404	New	+$201K	﹤0.01%	1357
2015 Q3	–	Sell	-4,565	Closed	-$204K	–	1597
2015 Q2	$204K	Buy	+4,565	New	+$172K	﹤0.01%	1501

Other funds holding DPLO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

ProShare Advisors's DPLO Position: Q3 2018 in Review

ProShare Advisors sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q3 2018, closing a stake of 9,034 shares — an estimated $231K sold.

ProShare Advisors first reported a position in DPLO in Q2 2015 and held it in 3 quarters. The position peaked at $231K in Q2 2018. 178 funds tracked by Wall St. Rank hold DPLO as of Q3 2018.

ProShare Advisors reported no remaining DIPLOMAT PHARMACY, INC. position as of Q3 2018 after selling out during the quarter.
ProShare Advisors sold 9,034 DIPLOMAT PHARMACY, INC. shares in Q3 2018, an estimated $231K.
ProShare Advisors first reported a position in DIPLOMAT PHARMACY, INC. in Q2 2015 and held it in 3 quarters.
ProShare Advisors's DIPLOMAT PHARMACY, INC. position peaked at $231K in Q2 2018.
178 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q3 2018.

Based on ProShare Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.